Insider Transactions in Q2 2022 at Rapt Therapeutics, Inc. (RAPT)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2022
|
Column Group Ii, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,800
+0.15%
|
$45,600
$12.45 P/Share
|
|
May 24
2022
|
Column Group Ii, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
32,628
+1.26%
|
$391,536
$12.0 P/Share
|
|
May 23
2022
|
Column Group Ii, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,472
+0.81%
|
$245,664
$12.5 P/Share
|
|
May 10
2022
|
Wendye Robbins |
BUY
Open market or private purchase
|
Indirect |
2,500
+17.53%
|
$25,000
$10.73 P/Share
|
|
May 10
2022
|
Wendye Robbins |
BUY
Open market or private purchase
|
Direct |
4,500
+15.19%
|
$49,500
$11.17 P/Share
|
|
May 10
2022
|
Rodney Kb Young CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
5,000
+33.15%
|
$50,000
$10.53 P/Share
|
|
May 10
2022
|
Column Group Ii, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,500,000
+50.0%
|
$25,000,000
$10.67 P/Share
|
|
May 04
2022
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
720
-3.51%
|
$10,800
$15.05 P/Share
|
|
Apr 11
2022
|
William Ho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
920
+1.67%
|
$11,040
$12.0 P/Share
|
|
Apr 11
2022
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,647
-11.79%
|
$60,881
$23.05 P/Share
|
|
Apr 11
2022
|
Dirk G. Brockstedt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,647
+10.54%
|
$15,882
$6.18 P/Share
|
|
Apr 06
2022
|
William Ho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,000
-5.32%
|
$66,000
$22.96 P/Share
|
|
Apr 04
2022
|
William Ho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
695
+1.22%
|
$4,170
$6.3 P/Share
|